Literatur
Vaidya JS, Wenz F, Bulsara M et al (2014) Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet 383:603–613
Zietman A (2015) Letters regarding the TARGIT-a trial: the editor’s introduction. Int J Radiat Oncol Biol Phys 92:951–952
Veronesi U, Orecchia R, Maisonneuve P et al (2013) Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol 14:1269–1277
Olivotto IA, Whelan TH, Parpia S et al (2013) Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy. J Clin Oncol 31:4038–4045
Livi L, Meattini I, Marrazzo L et al (2015) Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial. Eur J Cancer 51:451–463
Polgár C, Fodor J, Major T et al (2013) Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial. Radiother Oncol 108:197–202
Vicini F, Shah C, Ben Wilkinson J et al (2013) Should ductal carcinoma in situ [DCIS] be removed from the ASTRO consensus panel cautionary for off-protocol use of accelerated partial breast irradiation [APBI]? A pooled analysis of outcomes for 300 patients, with DCIS treated with APBI. Ann Surg Oncol 20:1275–1281
Burotto M, Prasad V, Fojo T (2015) Non-inferiority trials: why oncologists must remain wary. Lancet Oncol 16:364–366
Vaidya JS, Bulsara M, Wenz F et al (2015) Pride, prejudice, or science: attitudes towards the results of the TARGIT-A trial of targeted intraoperative radiation therapy for breast cancer. Int J Radiat Oncol Biol Phys 92:491–497
Strnad V, Ott OJ, Hildebrandt G et al (2015) 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. Lancet. doi:10.1016/S0140-6736(15)00471-7
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
D. Krug gibt an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Rights and permissions
About this article
Cite this article
Krug, D. Akzelerierte Teilbrustbestrahlung mit interstitieller Multikatheter-Brachytherapie. Strahlenther Onkol 192, 127–129 (2016). https://doi.org/10.1007/s00066-015-0932-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00066-015-0932-1